Éthique

Dr. Kotluk is currently a post-doc at the EPFL. He focuses mainly on emotions in the decision-making process, moral reasoning, and ethics in Engineering Education. He also works on equality and diversity issues. He has an academic background in both STEM and social sciences. Dr. Kotluk has acquired advanced skills in education, inclusive pedagogy, and science teachers' training. He has 14 years of teaching experience and has trained high school students in physics and teachers in pedagogy and research methods, among others.  Dr. Kotluk has strong teaching and learning communication skills. He holds a Ph.D. in Educational Science, Curriculum, and Instruction. In his thesis, he studied the perceptions and practices of educators in culturally relevant pedagogy and developed recommendations to put more emphasis on inclusion in pre-service teacher education. With his research, he opened a new discussion in the academic community in Turkey and internationally. In his recent work, he analyzes the educational challenges facing refugee communities and other marginalized groups.  In the study, he focused on whether and how teachers implemented the principles of culturally relevant and sustaining pedagogies and the challenges teachers faced while trying to implement these principles with Syrian students in Turkey. In his more recent work, he has studied moral emotions, moral reasoning in engineering ethics, and equality and diversity issues in engineering education. His teaching and research interests include emotions in engineering education, culturally responsive STEM education, equity and diversity in education, and multicultural education.

Patrick Aebischer a achevé une formation en Médecine (1980) et en Neurosciences (1983) aux Universités de Genève et de Fribourg en Suisse. De 1984 à 1992, Patrick Aebischer a travaillé à Brown University (USA) au sein du Département des Neurosciences et au Département des Biomatériaux et des Organes Artificiels en tant que Professeur assistant, puis Professeur associé. En 1992, Patrick Aebischer a été nommé Professeur de la Division Autonome de Recherche Chirurgicale et du Centre de Thérapie Génique (DARC) au Centre Hospitalier Universitaire Vaudois (CHUV) à Lausanne. En 1999, Le Conseil Fédéral a nommé Patrick Aebischer en tant que Président de l'Ecole Polytechnique Fédérale de Lausanne (EPFL). Il a pris ses fonctions à la Présidence de l’EPFL en mars 2000, position qu'il a occupée jusqu'au 31 décembre 2016. Patrick Aebischer est membre de maintes sociétés professionnelles, tant en Europe qu’aux Etats-Unis. Patrick Aebischer a fondé trois start-up de biotechnologies. Il siège au conseil d'administration de Lonza, de Logitech et de Nestlé. Il préside également l'advisory board du Novartis Venture Fund. Patrick Aebischer est membre du conseil de fondation du Festival de Jazz de Montreux, du Festival de Verbier et de la Fondation Jacobs. Les recherches qu’il poursuit actuellement dans son laboratoire se concentrent sur le développement d'approches de thérapie cellulaire et de transfert génique pour le traitement des maladies neurodégénératives.

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

ACADEMIC POSITION: Professor, Director of the Laboratory of Behavioral Genetics, Brain Mind Institute, Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland. EDUCATION: • BS MS Salamanca, Spain, 1984 • PhD Cajal Institute, CSIC, and University Autonoma of Madrid, Spain, 1988 PROFESSIONAL EXPERIENCE: • Postdoc at INSERM, Bordeaux, France, and Cajal Institute Madrid, Spain, 1989-1990 • Postdoc at the Open University, UK, 1991-1992, 1996 • Research Associate, Cajal Institute, CSIC, Madrid, 1993-1995 • Associate Professor Tenured, UNED University, Madrid, 1996-2003 • Sabbatical Professor, University of Bern, Switzerland, 2002-2003 • Assistant Professor Tenure-Track, EPFL, 2003-2007 • Associate Professor Tenured, EPFL, 2007-2012 • Full Professor, EPFL, 2012- • Director, Brain Mind Institute, EPFL, 2012- PRINCIPAL BOARDS: • President, European Brain and Behavior Society (EBBS), 2009-2012 • Editor-in-Chief “Frontiers in Behavioral Neuroscience” • Member of Scientific Advisory Panel, European College Neuropsychopharmacology (ECNP) • Member of the European Dana Alliance for the Brain (EDAB) • Associate Editor “Frontiers in Neuroscience” • Editorial Board Member “Neurobiology of Learning and Memory” • Editorial Board Member “Journal of Psychiatry Research” • Editorial Board Member “Stress” • Editorial Board Member “Biology of Mood and Anxiety Disorders” • Editorial Board Member “Neuroscience and Biobehavioral Reviews”

Dr. Marcello Ienca is a Principal Investigator at the College of Humanities at EPFL where he leads the ERA-NET funded Intelligent Systems Ethics research unit. He is also an affiliate member of the Health Ethics and Policy unit, Department of Health Sciences and Technology, and an ordinary member of the Competence for Rehabilitation Engineering & Science at ETH Zurich, Switzerland. Dr. Ienca's scholarship focuses on the ethical, legal, social and policy implications of emerging technologies. In particular, he investigates the broader implications of new (and often converging) sociotechnical trends such as Artificial Intelligence (AI), big data, digital epidemiology, robotics, assisted living, digital health, social media, dual use, and neurotechnology. He and his team use both theoretical and empirical methods to explore the requirements for responsible innovation, ethically-​aligned technology design, user-​centred design, and human-​centered technology assessment. Dr. Ienca is actively involved in science and technology policy within international organizations and professional societies. In particular, he is an appointed member of the Organisation for Economic Co-​operation and Development’s (OECD) Steering Committee on Neurotechnology and the representative of the Swiss Delegation (appointed by the Swiss State Secretariat for Education, Research and Innovation, SERI). He has also been invited to serve as an expert advisor to the Council of Europe’s Ad Hoc Committee on Artificial Intelligence and the Bioethics Committee. Dr. Ienca has written reports for the OECD, the Council of Europe, and the European Parliament's Panel for the Future of Science and Technology. He is a Member of the Board of Directors of the Italian Neuroethics Society (SINe), a former Board Member and current member of the Nominating Committee of the International Neuroethics Society (INS). Ienca is a member of the Editorial Board of several academic journals such as Neuroethics, Bioethica Forum, Frontiers in Neuroergonomics and Frontiers in Genetics. Ienca has received several awards for social responsibility in science and technology such as the Vontobel Award for Ageing Research (Switzerland), the Prize Pato de Carvalho (Portugal), the Sonia Lupien Award (Canada), the Paul Schotsmans Prize from the European Association of Centres of Medical Ethics (EACME) and the Data Privacy Plaque of Honour, awarded by the Italian Data Protection Authority. He has authored one monograph, several edited volumes, 60 scientific articles in peer-​review journals, several book chapters and is a frequent contributor to Scientific American. His research was featured in academic journals such as Neuron , Nature Biotechnology , Nature Machine Intelligence , Nature Medicine and media outlets such as Nature , The New Yorker , The Guardian , The Times , Die Welt , The Independent , the Financial Times and others. Furthermore, Dr. Ienca strongly supports open science, outreach and public engagement. He is committed to a holistic view of research that is not restricted to academia alone but involves an open approach to science communication, outreach and public engagement. Among other things, he is an open-​science and open-​data enthusiast and a human rights activist. He believes that there can be no ethical technological innovation without global justice.

Awards: 1999 Young Investigator Award Plenary Lectureship , International Society for Neurochemistry 2011 Fellow , ESMRMB 2011 Teaching Award , Section Sciences de la Vie, EPFL